Novel ITP Drug Helps Patients Ditch Daily Meds

(MedPage Today) — ORLANDO — Adding four monthly infusions of novel ianalumab helped adults with primary immune thrombocytopenia (ITP) achieve durable disease control in the second-line setting while stopping daily treatment with an oral platelet…

Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118904

Author :

Publish date : 2025-12-09 15:09:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Novel ITP Drug Helps Patients Ditch Daily Meds

Timing cancer drug delivery around our body clock may boost survival

New BTK Inhibitor Makes Case for Earlier Use in CLL

Related Posts

Corridor Care ‘Routine’ as A&E Capacity Stretched

First Patient With RDEB Treated With New Gene Therapy

Number of Hospitals Equipped to Handle Pediatric Cases on the Decline

Ketamine Not a Better Anesthetic for Intubation of Critically Ill Patients

Dinosaurs like Diplodocus may have been as colourful as birds

Energy Drinks Blamed for Man’s Severe High Blood Pressure, Stroke

Corridor Care ‘Routine’ as A&E Capacity Stretched

First Patient With RDEB Treated With New Gene Therapy

Number of Hospitals Equipped to Handle Pediatric Cases on the Decline

Ketamine Not a Better Anesthetic for Intubation of Critically Ill Patients

Dinosaurs like Diplodocus may have been as colourful as birds

Energy Drinks Blamed for Man’s Severe High Blood Pressure, Stroke

Rare Temporary Flu Complication Can Leave Some Kids Unable to Walk

Material Hardship, ‘Catastrophic’ Income Loss Common in Families of Kids With ALL

Categories

Archives